Psychedelic Drugs Market
Psychedelic Drugs Market - Global Industry Assessment & Forecast
#
Pages:
197
Base Year:
2023
Feb - 2024
Format:
Report Code:
VMR-2432
Segments Covered
By
Source Synthetic, Natural
-
By
Therapeutic Drugs Psilocybin, LSD, MDMA, DMT, Ketamine
-
By
Route of Administration Oral, Injectable, Inhalation
-
By
Indication Alzheimer Dementia, Anorexia and Obesity, Anxiety & Depressive Disorders, Cluster Headaches, Obsessive Compulsive Disorders, Personality Disorder, Post-Traumatic Stress Disorder, Substance Abuse Disorders, Terminal Cancer Distress
-
By
Distribution Channel Hospital Pharmacies (Dominating 57.3%), Retail Pharmacies, Online Pharmacies
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 2.91 Billion |
 Revenue 2032:
|
USD 8.85 Billion |
 Revenue CAGR
(2024 - 2032): |
13.2% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Psychedelic Drugs Market Segment Analysis
- Psychedelic Drugs Source Outlook (Revenue, USD Million, 2018 - 2030)
- Synthetic
- Natural
- Psychedelic Drugs Therapeutic Drugs Outlook (Revenue, USD Million, 2018 - 2030)
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Psychedelic Drugs Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Injectable
- Inhalation
- Psychedelic Drugs Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Psychedelic Drugs Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Psychedelic Drugs Market, by Source
- Synthetic
- Natural
-
North America Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
-
North America Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
-
North America Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
-
North America Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- U.S.
- U.S. Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- U.S. Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- U.S. Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- U.S. Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- U.S. Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- U.S. Psychedelic Drugs Market, by Source
- Canada
- Canada Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Canada Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Canada Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Canada Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Canada Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Canada Psychedelic Drugs Market, by Source
-
Mexico
- Mexico Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Mexico Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Mexico Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Mexico Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Mexico Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Mexico Psychedelic Drugs Market, by Source
-
North America Psychedelic Drugs Market, by Source
- Europe
-
Europe Psychedelic Drugs Market, by Source
- Synthetic
- Natural
-
Europe Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
-
Europe Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
-
Europe Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
-
Europe Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- U. K.
- U.K. Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- U.K. Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- U.K. Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- U.K. Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- U.K. Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- U.K. Psychedelic Drugs Market, by Source
- France
- France Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- France Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- France Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- France Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- France Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- France Psychedelic Drugs Market, by Source
-
Germany
- Germany Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Germany Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Germany Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Germany Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Germany Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Germany Psychedelic Drugs Market, by Source
-
Italy
- Italy Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Italy Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Italy Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Italy Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Italy Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Italy Psychedelic Drugs Market, by Source
-
Spain
- Spain Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Spain Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Spain Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Spain Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Spain Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Spain Psychedelic Drugs Market, by Source
-
Rest of Europe
- Rest of Europe Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Rest of Europe Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Rest of Europe Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Rest of Europe Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Rest of Europe Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Rest of Europe Psychedelic Drugs Market, by Source
-
Europe Psychedelic Drugs Market, by Source
- Asia Pacific
-
Asia Pacific Psychedelic Drugs Market, by Source
- Synthetic
- Natural
-
Asia Pacific Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
-
Asia Pacific Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
-
Asia Pacific Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
-
Asia Pacific Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- China
- China Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- China Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- China Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- China Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- China Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- China Psychedelic Drugs Market, by Source
- Japan
- Japan Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Japan Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Japan Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Japan Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Japan Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Japan Psychedelic Drugs Market, by Source
-
Germany
- Germany Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Germany Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Germany Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Germany Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Germany Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Germany Psychedelic Drugs Market, by Source
-
India
- India Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- India Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- India Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- India Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- India Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- India Psychedelic Drugs Market, by Source
-
South Korea
- South Korea Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- South Korea Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- South Korea Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- South Korea Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- South Korea Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- South Korea Psychedelic Drugs Market, by Source
-
South East Asia
- South East Asia Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- South East Asia Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- South East Asia Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- South East Asia Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- South East Asia Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- South East Asia Psychedelic Drugs Market, by Source
-
Rest of Asia Pacific
- Rest of Asia Pacific Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Rest of Asia Pacific Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Rest of Asia Pacific Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Rest of Asia Pacific Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Rest of Asia Pacific Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Rest of Asia Pacific Psychedelic Drugs Market, by Source
-
Asia Pacific Psychedelic Drugs Market, by Source
- Latin America
-
Latin America Psychedelic Drugs Market, by Source
- Synthetic
- Natural
-
Latin America Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
-
Latin America Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
-
Latin America Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
-
Latin America Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Brazil
- Brazil Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Brazil Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Brazil Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Brazil Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Brazil Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Brazil Psychedelic Drugs Market, by Source
- Argentina
- Argentina Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Argentina Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Argentina Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Argentina Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Argentina Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Argentina Psychedelic Drugs Market, by Source
-
Rest of Latin America
- Rest of Latin America Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Rest of Latin America Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Rest of Latin America Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Rest of Latin America Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Rest of Latin America Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Rest of Latin America Psychedelic Drugs Market, by Source
-
Latin America Psychedelic Drugs Market, by Source
- Middle East & Africa
-
Middle East & Africa Psychedelic Drugs Market, by Source
- Synthetic
- Natural
-
Middle East & Africa Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
-
Middle East & Africa Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
-
Middle East & Africa Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
-
Middle East & Africa Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- GCC Countries
- GCC Countries Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- GCC Countries Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- GCC Countries Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- GCC Countries Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- GCC Countries Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- GCC Countries Psychedelic Drugs Market, by Source
- South Africa
- South Africa Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- South Africa Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- South Africa Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- South Africa Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- South Africa Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- South Africa Psychedelic Drugs Market, by Source
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Psychedelic Drugs Market, by Source
- Synthetic
- Natural
- Rest of Middle East & Africa Psychedelic Drugs Market, by Therapeutic Drugs
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Rest of Middle East & Africa Psychedelic Drugs Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Rest of Middle East & Africa Psychedelic Drugs Market, by Indication
- Alzheimer Dementia
- Anorexia and Obesity
- Anxiety & Depressive Disorders
- Cluster Headaches
- Obsessive Compulsive Disorders
- Personality Disorder
- Post-Traumatic Stress Disorder
- Substance Abuse Disorders
- Terminal Cancer Distress
- Rest of Middle East & Africa Psychedelic Drugs Market, by Distribution Channel
- Hospital Pharmacies (Dominating 57.3%)
- Retail Pharmacies
- Online Pharmacies
- Rest of Middle East & Africa Psychedelic Drugs Market, by Source
-
Middle East & Africa Psychedelic Drugs Market, by Source
- North America
FAQ
Frequently Asked Question
What is the global demand for Psychedelic Drugs in terms of revenue?
-
The global Psychedelic Drugs valued at USD 2.91 Billion in 2023 and is expected to reach USD 8.85 Billion in 2032 growing at a CAGR of 13.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Atai Life Sciences NV, Compass Pathways PLC, MindMed Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc., Alkermes, Celon Pharma S.A, Seelos Therapeutics Inc., HAVN Life Sciences Inc., Numinus Wellness Inc., Eli Lilly and Company.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 13.2% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Psychedelic Drugs include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Psychedelic Drugs in 2023.
